Skip to content
Trial Eligibility
Menu

OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression

NCT06991166

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Postpartum Depression (PPD) is defined as depression that occurs after childbirth, with intense symptoms that last longer than "baby blues". PPD differs greatly from "baby blues", a term used to describe the typical sadness, worry and tiredness that women experience after childbirth, which often resolves within a week or two on its own. The symptoms of PPD interfere with many aspects of daily living and can have unhealthy short-term and long-term outcomes, both for the mother and baby. One-third of women in the U.S.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Post Partum Depression

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Hackensack Meridian Health
Last updated on ClinicalTrials.gov
September 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 1

  • Hackensack University Medical Center · Hackensack, NJ

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.